Health Highlight: Mon. 8, May.
Today’s Highlight(s): A recap of FDA Commissioner, Dr. Robert Califf’s Keynote speech at the 2023 Science for Patient Engagement Symposium.
Health Highlights workflow is powered by Glasp.co and Perplexity.ai; produced using iA Writer and Keynote.
Have a question? Want to be a sponsor? Get in touch: carlosfranco.bio
🧠 Learn, ❤️ Like, 🤝 Share, and 📩 Subscribe!
THE BRIEF
This morning, as the Keynote Speaker for the 2023 Science of Patient Engagement Symposium focused on Patient Empowerment and Digital Health, Robert M. Califf, MD, spoke first about the benefits of patient engagement and empowerment in managing healthcare. He specifically highlighted two programs—the Patient-Focused Drug Development (PFDD) and the Patient Representative Program—that have demonstrated improved outcomes for patients.
He then turned his remarks to address the rapidly advancing digital technologies that carry with them both incredible potential and risks, particularly the use of technologies that power some of the newest AI programs like ChatGPT.
“But this is where the rapid advance of digital technology is likely to disrupt our current methods. We have enormous potential as the world enters the 4th industrial revolution in which rich and diverse sources of digital data are available at scale in real-time with potentially unlimited storage capacity, and these data are becoming widely available as part of the clinical care system. Large language models are the next step that appears to be ushering in the revolution that many of us were hoping for.” 1
Going beyond the use of digital health technologies for research and treatment development, Dr. Robert Califf expanded his focus on the application of these advancements in helping with regulatory decisions and addressing issues including health disparities, better representation, mitigating misinformation, and countering algorithmic bias.
Dr. Robert Califf’s closing remarks…
“Across industry, digitization and insertion of machine learning and other types of mathematical algorithms into everyday life is making a profound difference, but government agencies lag behind private industry. Quite simply, we need to assemble the resources to put in place these policies and tools and adaptively align our digital health efforts to support public health and regulatory innovation in a world that is changing rapidly.”
“The potential certainly exists, and we have good reason to hope that we will fulfill the enormous potential of digital health technologies and see more innovative solutions that can result in improved outcomes, but we’d better also preempt the risks.” 1
Keywords 🏷️: #SciencePatientEngagementSymposium #SPES #FDA #DigitalHealthTech #DHT
NOTES
“Speech by Robert M. Califf, M.D. to the 2023 Science for Patient Engagement Symposium: Patient Empowerment in the Digital Health Era” https://www.fda.gov/news-events/speeches-fda-officials/speech-robert-m-califf-md-2023-science-patient-engagement-symposium-patient-empowerment-digital